BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Telomerase

Below is an extended Telomerase patents listing. Click here to return to the Telomerase main in depth entry.

Patents :

US Patent No.Title
7413897 Primitive and proximal hepatic stem cells
7419826 Human schwannoma cell line
7419827 Cell lines
7419964 Treatment of HSV-related pathologies using ssDNA
7419975 Organic compounds
7420031 Intracellular delivery of small molecules, proteins, and nucleic acids
7420099 Transgenic animals and uses thereof
7422736 Somatic pluripotent cells
7422853 RNA interference using a universal target
7422899 Antibodies to the human prolactin receptor
7423119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
7419787 Mass spectrometric methods for detecting mutations in a target nucleic acid
7417125 Antibodies that bind a PRO1158 polypeptide
7417123 PRO4399 Antibodies
7413902 Feeder-free culture method for embryonic stem cells or primate primordial stem cells
7413904 Human embryonic stem cells having genetic modifications
7414062 Triazaspiro compounds useful for treating or preventing pain
7414170 Transgenic bovines capable of human antibody production
7415358 Molecular toxicology modeling
7416885 Proliferated cell lines and uses thereof
7416888 Cell lines
7417065 Immunosuppressant compounds and compositions
7417115 PRO6027 polypeptides
7417116 PRO7155 polypeptides
7423120 PRO19814 polypeptides
7423127 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
7429454 DNA probes useful in detecting .delta.-endotoxin-encoding sequences and uses thereof
7429467 Emulsion compositions
7429578 Tricyclic inhibitors of poly(ADP-ribose) polymerases
7429640 PRO6181 polypeptides
7429641 PRO9830 polypeptides
7429660 ATM inhibitors
7429690 Transgenic bovines having reduced prion protein production
7432101 Production of poxviruses with adherent or non adherent avian cell lines
7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
7432345 PRO1475 polypeptide
7427667 PRO9835 antibodies
7427638 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminois- oindoline-1,3-dione:, and methods of synthesis and compositions thereof
7427502 Methods for identifying stem cells based on nuclear morphotypes
7423130 PRO1158 polypeptides
7425319 Method for enhancing protective cellular responses to genotoxic stress in skin
7425448 Cardiomyocyte precursors from human embryonic stem cells
7425605 PRO1486 polypeptides
7425606 Method for screening peptides for use in immunotherapy
7425609 PRO4330 polypeptides
7425619 Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620 Fc.gamma.RIIB-specific antibodies and methods of use thereof
7425621 Antibodies against the PRO4401 polypeptide
7426441 Methods for determining renal toxins
7432369 Pyridyl-substituted porphyrin compounds and methods of use thereof
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional